Bruker Expands Clinical Microbiology and Infection Diagnostics Portfolio
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
BD and Magnolia Medical Technologies aim to help hospitals reduce blood culture contamination and improve testing accuracy.
In a demonstration, the technique distinguished between healthy samples and either cancerous or pre-cancerous cells with nearly 100 percent accuracy.
This Tech Guide from the March/April 2021 issue of Clinical Lab Products includes microbiology systems from Affinity Biosensors, Beckman Coulter Diagnostics, Becton Dickinson Integrated Diagnostics, Biomerieux, Qiagen, T2 Biosystems, Thermo Fisher Scientific, and more.
Karius has received approval from the New York State Department of Health's CLEP for its Karius Test for pathogen detection.
The kit combines the Steripath Gen2 initial specimen diversion device with additional supplies required for the collection of blood culture samples that are virtually free of contamination.
Hardy Diagnostics has released its latest chromogenic media, HardyCHROM Group A Strep agar, for selective cultivation of clinical specimens.